Guided Therapeutics receives $2.5 million grant from National Cancer Institute to commercialize non-invasive cervical cancer det
GTHP | Quote | Chart | News | PowerRating -- Guided Therapeutics, Inc. has received a $2.5 million matching grant from The National Cancer Institute (NCI), a division of National Institutes of Health, to bring to market and expand the array features for its LightTouch(TM) non-invasive cervical cancer detection technology. Both the partners are based in the US.
Guided Therapeutics is a developer of rapid and painless test for the early detection of disease that leads to cervical cancer.
The grant provides Guided Therapeutics to complete the regulatory process and begin manufacturing for the device and single-patient-use disposable.
Deal Value (US$ Million) 2.5
Deal Type Partnership
Sub-Category Other
Deal Status Announced: 2009-10-05
Deal Participants
Partner 1 (Company) The U.S. Department of Health and Human Services
Partner 2 (Company) The National Cancer Institute
Partner 3 (Company) Guided Therapeutics, Inc. (formerly SpectRx, Inc.)
Partner 4 (Company) National Institutes of Health
Deal Rationale
This grant provides significant non-dilutive resources for Guided Therapeutics to begin manufacturing LightTouch devices and disposables for an international launch.
For full details on (GTHP) GTHP. (GTHP) has Short Term PowerRatings at TradingMarkets. Details on (GTHP) Short Term PowerRatings is available at This Link.
- Guided Therapeutics Secures New Funding Commitment from Konica Minolta Opto - 02/06/10
- Guided Therapeutics, Inc. Receives New Funding Commitment from Konica Minolta Opto, Inc. to Expand Cancer Detection Product Line - 02/02/10
- BUYINS.NET: GTHP, ENAFF, ISCR, CDNTF Have Been Added To Naked Short Lists Today - 12/10/09
- Guided Therapeutics Provides Preview of FDA Pivotal Clinical Trial Results at National Cancer Institute Conference - 11/09/09
- Guided Therapeutics Non-Invasive Cervical Cancer Detection Device Trial Confirms Current Tests Miss Disease; Create High False P - 11/05/09
- More News >>


